Form 4: Interparfums Insider Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report 12 December 2025 4:23 PM

Philippe Benacin, a Director and 10% owner of Interparfums, exercised 25,000 stock options and simultaneously sold an equal number of common shares.

Summary

Philippe Benacin, President of Interparfums SA, Director, and 10% owner of Interparfums Inc. (IPAR), reported transactions through his personal holding company, Philippe Benacin Holding SAS.
On December 11, 2025, Benacin exercised options to acquire a total of 25,000 shares of common stock at an exercise price of $73.09 per share.
Concurrently, on December 11, 2025, he sold 25,000 shares of common stock at a weighted average price of $83.2385 per share.
These transactions resulted in no net change to his indirect beneficial ownership of common stock, which remained at 6,846,064 shares following the reported transactions.
The options exercised were part of five separate grants, each for 5,000 shares, with varying exercisable dates from December 31, 2020, to December 31, 2024, and an expiration date of December 30, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (cashless option exercise and sale) which is neutral in sentiment. It does not indicate a significant change in the insider's conviction or the company's prospects.

Positives

The sale price of $83.2385 per share is higher than the option exercise price of $73.09, indicating a profitable transaction for the insider on the exercised options.

Negatives

The insider sold 25,000 shares, which, while offset by option exercise, represents a disposition of company stock rather than an increase in direct holdings.

Future Outlook

Industry Context

Related Party Transactions

The transactions involve Philippe Benacin, a Director, 10% Owner, and President of Interparfums SA, acting through his personal holding company, Philippe Benacin Holding SAS, which is a related party.

Stakeholder Impact

Shareholders: No direct impact on share price from the transaction itself as it's a routine cashless exercise. The insider's overall beneficial ownership of common stock remains unchanged.
Employees: No direct impact mentioned.
Customers: No direct impact mentioned.
Suppliers: No direct impact mentioned.
Creditors: No direct impact mentioned.

Key Dates

Date	Description
12/31/2020	Earliest date an option grant for 5,000 shares became exercisable.
12/31/2021	Date an option grant for 5,000 shares became exercisable.
12/31/2022	Date an option grant for 5,000 shares became exercisable.
12/31/2023	Date an option grant for 5,000 shares became exercisable.
12/31/2024	Date an option grant for 5,000 shares became exercisable.
12/11/2025	Date of common stock acquisition via option exercise and subsequent sale.
12/12/2025	Date the Form 4 was signed and filed by Philippe Benacin and Philippe Benacin Holding SAS.
12/30/2025	Expiration date for all exercised stock options.

Recommendation

hold

This Form 4 filing details a routine cashless exercise of stock options by a key insider, Philippe Benacin. While 25,000 shares were sold, an equal number were acquired through option exercise, resulting in no net change to his beneficial ownership of common stock. Such transactions are common for executive compensation and typically do not signal a change in the company's fundamentals or the insider's long-term view. Therefore, the filing itself does not provide new information to warrant a change in investment recommendation; a 'hold' stance is maintained based on existing company fundamentals.

Keywords

Interparfums, IPAR, Philippe Benacin, Insider Trading, Form 4, Stock Options, Share Sale, Beneficial Ownership, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.